抑制线粒体生物能量学与缺氧以增敏弥漫性内生性脑桥胶质瘤放疗
该研究通过DIPG模型与临床数据集分析线粒体代谢和缺氧特征,发现DIPG细胞依赖氧化磷酸化并存在缺氧,靶向线粒体可破坏生物能量学、缓解缺氧并增强放疗敏感性,作者认为值得进一步探索OXPHOS抑制作为放疗增敏策略。
要点
- DIPG细胞显示氧化磷酸化增强的特征。
- DIPG患者数据集中特定OXPHOS相关基因表达升高并存在缺氧基因表达特征。
- 原位小鼠DIPG模型中发现缺氧,靶向线粒体可增强放疗敏感性。
核心结论
- DIPG细胞依赖线粒体代谢生长,靶向线粒体可破坏生物能量学、缓解缺氧并增强放疗敏感性,作者认为值得进一步探索OXPHOS抑制作为DIPG放疗增敏策略。
研究设计与样本
- 研究使用DIPG模型并结合临床数据集,采用细胞外通量分析和靶向代谢组学检测线粒体代谢,并在体外和体内模型中探索靶向线粒体生物能量学和缺氧以实现放疗增敏的机制,同时分析治疗诱导的转录组学和代谢组学。
主要发现
- 对DIPG细胞的综合分析显示氧化磷酸化增强的特征。
- 在DIPG患者数据集中发现特定OXPHOS相关基因表达升高以及缺氧基因表达特征。
- 在携带DIPG肿瘤的原位小鼠模型中发现缺氧存在。
- 这些发现使研究者得以开发一种概念验证性治疗策略,在体外和动物模型中增强DIPG的放疗敏感性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse intrinsic pontine gliomas (DIPGs) and other H3K27M-mutated diffuse midline gliomas (DMGs) are brain tumors that primarily affect children. Radiotherapy is the standard of care but only provides only temporary symptomatic relief due to radioresistance. Although hypoxia is a major driver of radioresistance in other tumors, there is no definitive evidence that DIPGs are hypoxic. Diffuse intrinsic pontine gliomas often contain histone mutations, which alter tumor metabolism and are also associated with radioresistance. Our objective was to identify the metabolic profiles of DIPG cells, detect hypoxia signatures, and uncover metabolism-linked mechanisms of radioresistance to improve tumor radiosensitivity. METHODS: Using DIPG models combined with clinical datasets, we examined mitochondrial metabolism and signatures of hypoxia. We explored DIPG reliance on mitochondrial metabolism using extracellular flux assays and targeted metabolomics. In vitro and in vivo models were used to explore the mechanisms of targeting mitochondrial bioenergetics and hypoxia for radiosensitization. Treatment-induced transcriptomics and metabolomics were also investigated. RESULTS: Comprehensive analyses of DIPG cells show signatures of enhanced oxidative phosphorylation (OXPHOS). We also identified increased expression of specific OXPHOS-related genes and signatures of hypoxia gene expression in datasets obtained from DIPG patients. We found the presence of hypoxia in orthotopic mouse models bearing DIPG tumors. These findings enabled us to develop a proof-of-concept treatment strategy to enhance radiosensitivity of DIPGs in vitro and in animal models. CONCLUSIONS: Diffuse intrinsic pontine glioma cells rely on mitochondrial metabolism for growth, and targeting mitochondria disrupts bioenergetics, alleviates hypoxia, and enhances radiosensitivity. These findings warrant further exploration of OXPHOS inhibition as a radiosensitizing strategy for DIPG treatment.
引用
- Shen H, Mudassar F, Ma S, et al. Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma. Neuro Oncol. 2025. PMID: 39575457. doi:10.1093/neuonc/noae255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。